eMedicine Specialties > Dermatology > Reactive & Inflammatory Dermatoses

Lichen Simplex Chronicus

Author: Daniel J Hogan, MD, Clinical Professor of Internal Medicine (Dermatology), NOVA Southeastern University; Investigator, Hill Top Research, Florida Research Center
Coauthor(s): Stephen H Mason, MD, Assistant Professor of Dermatology, Medical College of Georgia; Siobahn M Bower, MD, Internal Medicine Resident, Creighton University
Contributor Information and Disclosures

Updated: Oct 10, 2008

Introduction

Background

Lichen simplex chronicus (LSC) is thickening of the skin with variable scaling that arises secondary to repetitive scratching or rubbing. Lichen simplex chronicus is not a primary process. Rather, a person senses pruritus in a specific area of skin (with or without underlying pathology) and causes mechanical trauma to the point of lichenification.

A proposed variant of lichen simplex chronicus is lichen amyloidosis. Lichen amyloidosis is described as lichen simplex chronicus in which the keratinocytes have necrosed and formed keratinocytic-derived amyloid in the dermis. The initial insult is pruritus with resultant amyloid formation, rather than the reverse.1,2

Pathophysiology

Lichen simplex chronicus is found on the skin in regions accessible to scratching. Pruritus provokes rubbing that produces clinical lesions, but the underlying pathophysiology is unknown. Some skin types are more prone to lichenification, such as skin that tends toward eczematous conditions (ie, atopic dermatitis, atopic diathesis). A relationship likely exists between central and peripheral neural tissue and inflammatory cell products in the perception of itch and ensuing changes in lichen simplex chronicus. The possible interplay among primary lesions, psychic factors, and the intensity of pruritus additively influence the extent and severity of lichen simplex chronicus.

A small study looking at lichen simplex chronicus and the use of P-phenylenediamine (PPD)–containing hair dye showed clinically relevant improvement in symptoms after discontinuation of PPD exposure, thus providing a basis for the role of sensitization and contact dermatitis in the etiology of lichen simplex chronicus.

Frequency

International

Exact frequency in the general population is unknown. In one study, 12% of aging patients with pruritic skin had lichen simplex chronicus.

Mortality/Morbidity

No mortality occurs as a result of lichen simplex chronicus. Overall, pruritus of lichen simplex chronicus is mild to moderate, but paroxysms may occur that are relieved by moderate-to-severe rubbing and scratching. Pruritus is usually described as much worse during periods of inactivity, usually at bedtime and during the night. Touch and emotional stress also may provoke pruritus, which is relieved by moderate-to-severe rubbing and scratching.

  • Lesions cause little direct morbidity; however, occasionally patients report decreased or interrupted sleep, which affects motor and mental functioning.
  • Lichen simplex chronicus SC may become secondarily infected after excoriation.
  • Lichen simplex chronicus is often visible enough to cause patients to seek treatment.

Race

No differences are reported in frequency among races, although prior authors claimed lichen simplex chronicus was more common in Asians and African Americans. The appearance of lesions on darker skin sometimes shows follicular prominence. Secondary pigmentary alterations are also more severe in individuals with darker skin.

Sex

Lichen simplex chronicus is observed more commonly in females than in males. Lichen nuchae is a form of lichen simplex that occurs on the midposterior neck and is observed almost exclusively in women.

Age

Lichen simplex chronicus occurs mostly in mid-to-late adulthood, with highest prevalence in persons aged 30-50 years.

Clinical

History

  • Patients with lichen simplex chronicus usually describe stable pruritic plaques on one or more areas; however, thickening of the skin occurs on any location that the patient can reach, including the following:
    • Scalp
    • Nape of neck
    • Extensor forearms and elbows
    • Vulva and scrotum3
    • Upper medial thighs, knees, lower legs, and ankles
  • Erythema is noted most in early lesions.
  • Pruritus is described as worse when patients are still or quiet and as much less or nonexistent when patients are active.
  • Pruritus is usually intermittent; the resultant scratching provides temporary relief.
  • Patients may have a past medical history of a chronic skin condition or acute trauma. Patients with atopic dermatitis may have lichen simplex chronicus in areas of former atopic outbreaks. Sites of irritant or allergic contact dermatitis, insect bites, or other past minor skin trauma sometimes demonstrate pruritus and, subsequently, lichen simplex chronicus.
  • Each palm-sized plaque may have 3 zones. A 2- to 3-cm wide peripheral zone that is barely thickened may have isolated papules. The middle zone has lenticular and hemispheric prurigo papules that may be excoriated. The central zone has the greatest thickening and pigmentary alteration.

Physical

  • One or more slightly erythematous, scaly, well-demarcated, lichenified, firm, rough plaques with exaggerated skin lines are noted.
  • Pigmentary changes (especially hyperpigmentation) are seen variably as in any dermatitic lesion.
  • Rubbing plays a key role in lesion formation and is visualized variably by white scratch marks, erosion, and ulceration from deeper scratching.
  • Lichen simplex chronicus is one of the hyperkeratotic processes from which a cutaneous horn may grow.4
  • Patients may scratch lesions de novo when observed. Some patients may start scratching while discussing the itch or describing the lesions.

Causes

  • Atopic dermatitis results in a higher probability of developing lichen simplex chronicus.
  • Insect bites, scars (eg, traumatic, postherpetic/zoster5 ), acne keloidalis nuchae,6 xerosis, venous insufficiency, and asteatotic eczema are common factors.
  • Psychological factors appear to play a role in the development or exacerbation of lichen simplex chronicus.7
    • Anxiety has been reported to be more prevalent in patients with lichen simplex chronicus.
    • Neurodermatitis is a term formerly used interchangeably with lichen simplex chronicus, suggesting a role of anxiety or obsession as part of the pathological process of developing lesions.
  • Lithium has been linked to lichen simplex chronicus in one reported case. Lichen simplex chronicus was dependent on the administration of lithium as evidenced by the observation that the lichen simplex chronicus remitted when the medication was discontinued and recurred when it was restarted.8
  • A small study looking at lichen simplex chronicus and the use of PPD-containing hair dye showed clinically relevant improvement in symptoms after discontinuation of PPD exposure, thus providing a basis for the role of sensitization and contact dermatitis in the etiology of lichen simplex chronicus.9
  • Long-term exposure to street traffic exhaust has been associated with an increase in the frequency of childhood skin diseases, including lichen simplex chronicus.10
  • Some reserve the diagnosis of lichen simplex for patients who have no known predisposing skin disorder. The term secondary lichenification has been used if the eruption is initiated by a primary dermatosis.

More on Lichen Simplex Chronicus

Overview: Lichen Simplex Chronicus
Differential Diagnoses & Workup: Lichen Simplex Chronicus
Treatment & Medication: Lichen Simplex Chronicus
Follow-up: Lichen Simplex Chronicus
Multimedia: Lichen Simplex Chronicus
References

References

  1. Weyers W, Weyers I, Bonczkowitz M, Diaz-Cascajo C, Schill WB. Lichen amyloidosus: a consequence of scratching. J Am Acad Dermatol. Dec 1997;37(6):923-8. [Medline].

  2. Weyers W. [Lichen amyloidosus--disease entity or the effect of scratching]. Hautarzt. Mar 1995;46(3):165-72. [Medline].

  3. Ball SB, Wojnarowska F. Vulvar dermatoses: lichen sclerosus, lichen planus, and vulval dermatitis/lichen simplex chronicus. Semin Cutan Med Surg. Sep 1998;17(3):182-8. [Medline].

  4. Khaitan BK, Sood A, Singh MK. Lichen simplex chronicus with a cutaneous horn. Acta Derm Venereol. May 1999;79(3):243. [Medline].

  5. Gerritsen MJ, Gruintjes FW, Andreissen MA, van der Valk PG, van de Kerkhof PC. Lichen simplex chronicus as a complication of herpes zoster. Br J Dermatol. May 1998;138(5):921-2. [Medline].

  6. Burkhart CG, Burkhart CN. Acne keloidalis is lichen simplex chronicus with fibrotic keloidal scarring. J Am Acad Dermatol. Oct 1998;39(4 Pt 1):661. [Medline].

  7. Woodruff PW, Higgins EM, du Vivier AW, Wessely S. Psychiatric illness in patients referred to a dermatology-psychiatry clinic. Gen Hosp Psychiatry. Jan 1997;19(1):29-35. [Medline].

  8. Shukla S, Mukherjee S. Lichen simplex chronicus during lithium treatment. Am J Psychiatry. Jul 1984;141(7):909-10. [Medline].

  9. Chey WY, Kim KL, Yoo TY, Lee AY. Allergic contact dermatitis from hair dye and development of lichen simplex chronicus. Contact Dermatitis. Jul 2004;51(1):5-8. [Medline].

  10. Ising H, Lange-Asschenfeldt H, Lieber GF, Weinhold H, Eilts M. [Effects of long-term exposure to street traffic exhaust on the development of skin and respiratory tract diseases in children]. Schriftenr Ver Wasser Boden Lufthyg. 2003;81-99. [Medline].

  11. Thaipisuttikul Y. Pruritic skin diseases in the elderly. J Dermatol. Mar 1998;25(3):153-7. [Medline].

  12. Brunner N, Yawalkar S. A double-blind, multicenter, parallel-group trial with 0.05% halobetasol propionate ointment versus 0.1% diflucortolone valerate ointment in patients with severe, chronic atopic dermatitis or lichen simplex chronicus. J Am Acad Dermatol. Dec 1991;25(6 Pt 2):1160-3. [Medline].

  13. Datz B, Yawalkar S. A double-blind, multicenter trial of 0.05% halobetasol propionate ointment and 0.05% clobetasol 17-propionate ointment in the treatment of patients with chronic, localized atopic dermatitis or lichen simplex chronicus. J Am Acad Dermatol. Dec 1991;25(6 Pt 2):1157-60. [Medline].

  14. Geraldez MC, Carreon-Gavino M, Hoppe G, Costales A. Diflucortolone valerate ointment with and without occlusion in lichen simplex chronicus. Int J Dermatol. Nov 1989;28(9):603-4. [Medline].

  15. Drake LA, Millikan LE. The antipruritic effect of 5% doxepin cream in patients with eczematous dermatitis. Doxepin Study Group. Arch Dermatol. Dec 1995;131(12):1403-8. [Medline].

  16. Kantor GR, Resnik KS. Treatment of lichen simplex chronicus with topical capsaicin cream. Acta Derm Venereol. Mar 1996;76(2):161. [Medline].

  17. Yosipovitch G, Sugeng MW, Chan YH, Goon A, Ngim S, Goh CL. The effect of topically applied aspirin on localized circumscribed neurodermatitis. J Am Acad Dermatol. Dec 2001;45(6):910-3. [Medline].

  18. Kelekci HK, Uncu HG, Yilmaz B, Ozdemir O, Sut N, Kelekci S. Pimecrolimus 1% cream for pruritus in postmenopausal diabetic women with vulvar lichen simplex chronicus: A prospective non-controlled case series. J Dermatolog Treat. Apr 11 2008;1-5. [Medline].

  19. Heckmann M, Heyer G, Brunner B, Plewig G. Botulinum toxin type A injection in the treatment of lichen simplex: an open pilot study. J Am Acad Dermatol. Apr 2002;46(4):617-9. [Medline].

  20. Ferry AP, Kaltreider SA. Lichen simplex chronicus of the eyelid. Arch Ophthalmol. Jun 1999;117(6):829-31. [Medline].

  21. Frithz A, Lagerholm B. Lichen simplex chronicus Vidal: comparative submicroscopic aspects of acanthotic disorders. Acta Derm Venereol. 1977;57(2):103-11. [Medline].

  22. Inoko M, Konishi T, Matsusue S, Kobashi Y. Midmural fibrosis of left ventricle due to selenium deficiency. Circulation. Dec 8 1998;98(23):2638-9. [Medline].

  23. Jacob CI, Patten SF. Strongyloides stercoralis infection presenting as generalized prurigo nodularis and lichen simplex chronicus. J Am Acad Dermatol. Aug 1999;41(2 Pt 2):357-61. [Medline].

  24. Kinsella LJ, Carney-Godley K, Feldmann E. Lichen simplex chronicus as the initial manifestation of intramedullary neoplasm and syringomyelia. Neurosurgery. Mar 1992;30(3):418-21. [Medline].

  25. O'Keefe RJ, Scurry JP, Dennerstein G, Sfameni S, Brenan J. Audit of 114 non-neoplastic vulvar biopsies. Br J Obstet Gynaecol. Oct 1995;102(10):780-6. [Medline].

Further Reading

Keywords

lichen simplex chronicus, neurodermatitis circumscripta, circumscribed neurodermatitis, lichen simplex chronicus of Vidal, LSC, lichen amyloidosis, atopic dermatitis, lichen simplex, secondary lichenification, atopic diathesis, lichen simplex, cutaneous horn, lichenification

Contributor Information and Disclosures

Author

Daniel J Hogan, MD, Clinical Professor of Internal Medicine (Dermatology), NOVA Southeastern University; Investigator, Hill Top Research, Florida Research Center
Daniel J Hogan, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Contact Dermatitis Society, and Canadian Dermatology Association
Disclosure: Nothing to disclose.

Coauthor(s)

Stephen H Mason, MD, Assistant Professor of Dermatology, Medical College of Georgia
Stephen H Mason, MD is a member of the following medical societies: American Academy of Dermatology, American College of Mohs Micrographic Surgery and Cutaneous Oncology, American Society for Dermatologic Surgery, Skin Cancer Foundation, and Women's Dermatologic Society
Disclosure: Nothing to disclose.

Siobahn M Bower, MD, Internal Medicine Resident, Creighton University
Siobahn M Bower, MD is a member of the following medical societies: American College of Physicians and American Medical Association
Disclosure: Nothing to disclose.

Medical Editor

James J Nordlund, MD, Professor Emeritus, Department of Dermatology, University of Cincinnati College of Medicine
James J Nordlund, MD is a member of the following medical societies: American Academy of Dermatology, Sigma Xi, and Society for Investigative Dermatology
Disclosure: Nothing to disclose.

Pharmacy Editor

Richard P Vinson, MD, Assistant Clinical Professor, Department of Dermatology, Texas Tech University School of Medicine; Consulting Staff, Mountain View Dermatology, PA
Richard P Vinson, MD is a member of the following medical societies: American Academy of Dermatology, Association of Military Dermatologists, Texas Dermatological Society, and Texas Medical Association
Disclosure: Nothing to disclose.

Managing Editor

Jeffrey Meffert, MD, Assistant Clinical Professor of Dermatology, University of Texas Health Science Center-San Antonio
Jeffrey Meffert, MD is a member of the following medical societies: American Academy of Dermatology, American Medical Association, Association of Military Dermatologists, and Texas Dermatological Society
Disclosure: Nothing to disclose.

CME Editor

Joel M Gelfand, MD, MSCE, Medical Director, Clinical Studies Unit, Assistant Professor, Department of Dermatology, Associate Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania
Joel M Gelfand, MD, MSCE is a member of the following medical societies: Society for Investigative Dermatology
Disclosure: AMGEN Consulting fee Consulting; AMGEN Grant/research funds None; Genentech Consulting fee Consulting; Centocor Consulting fee Consulting; Centocor Grant/research funds None; Covance Consulting fee Consulting; Shire  Consulting

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.